Resources

Index of Publications by Year - 2021

Publication Date:Accession Number:Title:
Data pager
Data pager
Page size :
PageSizeComboBox
select
Page 1 of 8, documents 1 to 50 of 381
12/08/2021 si010123 Standards of Practice - Insurance (Effective January 1, 2023)
12/08/2021 sc010123 Standards of Practice (Effective January 1, 2023)
12/08/2021 sg010123 Standards of Practice - General Standards (Effective January 1, 2023)
12/08/2021 221137 Final Standards – Changes Required by the Adoption in Canada of IFRS 17 (Insurance Contracts)
12/08/2021 spb010123 Standards of Practice - Post-Employment Benefit Plans (Effective January 1, 2023)
12/08/2021 221136 Memorandum: Final Standards – Changes Required by the Adoption in Canada of IFRS 17 (Insurance Contracts)
12/08/2021 aa21-1 Session 1: Managing managers: The professional managerial class
12/08/2021 aa21-8-Cheng Changes to the Alberta auto insurance system
12/08/2021 aa21-4 Session 4: IFRS 17 recoverability of acquisition expenses and financial statement disclosures
12/08/2021 aa21-7 Session 7: IFRS 17 – signoff on many IFRS issues
12/08/2021 aa21-5- Howard Session 5: New CIA life mortality table and recent experience studies
12/08/2021 aa21-17 Session 17: Facility Association’s IFRS 17 journey
12/08/2021 aa21-16 Session 16: CRMCR annual update
12/08/2021 aa21-12 Session 12: How big is too big? The tipping point for systematic failure
12/08/2021 aa21-13 Session 13: IFRS 17 and Canadian standards and practice – role of the AA
12/08/2021 aa21-6 Session 6: Reinsurance update
12/08/2021 aa21-2 Session 2: CLIFR updates (including IFRS 17)
12/08/2021 aa21-3 Session 3: PCFRC update
12/08/2021 aa21-15 Session 15: FCT and ORSA panel discussion
12/08/2021 aa21-14 Session 14: Life underwriting perspectives and trends
12/07/2021 act21-25 Session 25: CLIFR updates (including IFRS 17)
12/07/2021 act21-23 Session 23: Using good data for good: Making risk assessment fair and unbiased
12/07/2021 act21-21 Session 21: Hedging longevity risk in the Canadian market
12/07/2021 act21-42 Session 42: A North American flood risk model for (re)insurance purposes
12/07/2021 act21-40 Session 40: COVID actuarial challenges
12/07/2021 act21-36 Session 36: Making sense of mortality trends – modelling and considerations
12/07/2021 act21-31 Session 31: Pandemic risk management: Resources contingency planning and allocation
12/07/2021 act21-46 Session 46: IFRS 17 and Canadian Standards of Practice, role of Appointed Actuary
12/07/2021 act21-45 Session 45: Creating value in today's economy
12/07/2021 act21-26 Session 26: IFRS 17 Presentation and disclosures
12/07/2021 act21-44 Session 44: Wearable technology
12/07/2021 act21-35 Session 35: Risk assessment in the frame of climate change
12/07/2021 act21-39-Grandoit Session 39: Economic Outlook & Investment Strategy
12/07/2021 act21-41 Session 41: Institutional investors find alpha in climate risk matrices: Global survey finds
12/07/2021 act21-28 Session 28: Development in underwriting
12/07/2021 act21-34 Session 34: The impact of COVID-19 on Canadian mortality – Part II
12/07/2021 act21-38 Session 38: Group insurance trend
12/07/2021 act21-39-Kavcic Session 39: Economic Outlook & Investment Strategy
12/07/2021 ACT21-20 Session 20: The Canadian judges’ science manual and its guidance and perspective for actuaries
12/07/2021 act21-17 Session 17: Liability driven investment – pension surplus risk
12/07/2021 act21-11 Session 11: Medical considerations & experience analysis in a post-COVID-19 world – short-term versus long-term impacts
12/07/2021 act21-15 Session 15: Regulatory perspectives on climate change risk to insurers and the financial system
12/07/2021 act21-8 Session 8: Office of the Superintendent of Financial Institutions – IFRS 17 MCT Quantitative Impact Study 2 & 3
12/07/2021 act21-9 Session 9: Underwriting, data, and ethics
12/07/2021 act21-7 Session 7: COVID-19 – Risk mitigation
12/07/2021 act21-14 Session 14: The role of actuaries in banking
12/07/2021 act21-18 Session 18: Covid-19: Setting the stage for a basic income plan
12/07/2021 act21-19 Session 19: LICAT & IFRS17 QIS2/3
12/07/2021 act21-6 Session 6: Critical illness, more than a product.
12/07/2021 act21-16 Session 16: Managing misrepresentation